ABL Diagnostics (XPAR:ABLD) Total Equity : €6.71 Mil (As of Jun. 2023)

View and export this data going back to 1989. Start your Free Trial

What is ABL Diagnostics Total Equity?

ABL Diagnostics's total equity for the quarter that ended in Jun. 2023 was €6.71 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

ABL Diagnostics Total Equity Historical Data

The historical data trend for ABL Diagnostics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Diagnostics Total Equity Chart

ABL Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Equity

Get a 7-Day Free Trial

7.15

7.09

2.36

2.62

6.75

ABL Diagnostics Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Equity	Get a 7-Day Free Trial															2.66	2.62	2.50	6.75	6.71

ABL Diagnostics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

ABL Diagnostics's Total Equity for the fiscal year that ended in Dec. 2022 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2022 )	-	Total Liabilities(Q: Dec. 2022 )
	=	15.408	-	8.654
	=	6.75

ABL Diagnostics's Total Equity for the quarter that ended in Jun. 2023 is calculated as

Total Equity	=	Total Assets(Q: Jun. 2023 )	-	Total Liabilities(Q: Jun. 2023 )
	=	16.372	-	9.661
	=	6.71

ABL Diagnostics Total Equity Related Terms

Thank you for viewing the detailed overview of ABL Diagnostics's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Diagnostics (XPAR:ABLD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ABL Diagnostics (XPAR:ABLD) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

72c, rue de, WOIPPY, Thionville, FRA, 57140

Website

https://www.abldiagnostics.com

ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.

ABL Diagnostics (XPAR:ABLD) Headlines

No Headlines